On September 14, CHINA LIFE fell 3.04% in regular trading, trading at HKD 28.72 per share, with turnover of HKD 286 million. The broader Life & Health Insurance sector traded lower in tandem, with AIA down 2.07%, PING AN down 1.20%, NCI down 1.51%, CHINA TAIPING down 1.03%, and YUNFENG FIN down 2.68%.

On the news front, the Ministry of Finance previously announced a RMB 35 billion capital injection into China Life Group, the largest single tranche among a combined RMB 70 billion package for five state-owned insurers. While the injection targets the group level rather than the listed entity — meaning near-term financial metrics of the listed company are not directly diluted — market sentiment remains under repeated adjustment as the sector absorbs the implications. Additionally, analysts have flagged that the company's first-half net profit of RMB 134.489 billion was heavily driven by equity market gains and fair value changes, raising concerns that profit could face pullback pressure if equity volatility intensifies in the second half.

Separately, China Life's Yili branch was recently fined RMB 501,000 for regulatory violations including providing policyholders with benefits outside contractual terms and improper sales practices.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)